Vimarsana
Biggest News Aggregation in the World

Page 4 - Sight Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sight Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sight Science Today - Breaking & Trending Today

Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript - Vimarsana News

Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript

SGHT earnings call for the period ending June 30, 2022.

Source: fool.com
Sizing Up Sight Sciences (NASDAQ:SGHT) - Vimarsana News

Sizing Up Sight Sciences (NASDAQ:SGHT)

Sight Sciences is seeing rapid revenue growth and over half of its market cap is net cash. Why am I still not enthusiastic about SGHT stock? Find out.

Financial Review: Nuvectra (OTCMKTS:NVTRQ) vs. Sight Sciences (NASDAQ:SGHT) - Vimarsana News

Financial Review: Nuvectra (OTCMKTS:NVTRQ) vs. Sight Sciences (NASDAQ:SGHT)

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

Sight Sciences, Inc. (SGHT) Q1 2022 Earnings Call Transcript - Vimarsana News

Sight Sciences, Inc. (SGHT) Q1 2022 Earnings Call Transcript

SGHT earnings call for the period ending March 31, 2022.

Source: fool.com
Financial Contrast: Nemaura Medical (NASDAQ:NMRD) vs. Sight Sciences (NASDAQ:SGHT) - Vimarsana News

Financial Contrast: Nemaura Medical (NASDAQ:NMRD) vs. Sight Sciences (NASDAQ:SGHT)

Nemaura Medical (NASDAQ:NMRD – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Analyst Recommendations This is a breakdown of current ratings […]